Company attributes
CEO
Founder
Investors
Founded Date
2016
Total Funding Amount (USD)
162,300,000
Latest Funding Round Date
January 2021
CFO
Latest Funding Type
Venture Capital Firm attributes
Invested in
Other attributes
Company Operating Status
Active
Juvenescence is a Douglas, Isle of Man based venture capital and development company. They focus their investments and development on companies developing therapeutic strategies to treat the tissue-specific signature and pathologies of aging and senescence. The strategy includes products targeted at slowing cellular aging, slowing and reversing neurodegeneration, destroying senescent cells, replacing aging organs and editing patient genes.
Investment
Juvenescence has invested in LyGenesis, Souvien Therapeutics, BYOMass, BHB Therapeutics, AgeX Therapeutics, Napa Therapeutics, FoxBio, Insilico Medicine, GenerAIt Pharmaceuticals and Netrapharma.
Timeline
No Timeline data yet.
Associated Investment Funds
Accelerator Batches
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Funding Rounds Participated In
Further Resources
No Further Resources data yet.
